| Basics |
ProShares Ultra Nasdaq Biotechnology
The investment seeks daily investment results that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology Index®.
The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the fund's investment objective. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified.
|
| IPO Date: |
April 8, 2010 |
| Sector: |
Biotech |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$1.34 | 1.94%
|
| Avg Daily Range (30 D): |
$1.11 | 1.46%
|
| Avg Daily Range (90 D): |
$0.98 | 1.54%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.18M |
| Avg Daily Volume (30 D): |
.02M |
| Avg Daily Volume (90 D): |
.01M |
| Trade Size |
| Avg Trade Size (Sh.): |
147 |
| Avg Trade Size (Sh.) (30 D): |
108 |
| Avg Trade Size (Sh.) (90 D): |
119 |
| Institutional Trades |
| Total Inst.Trades: |
762 |
| Avg Inst. Trade: |
$1.61M |
| Avg Inst. Trade (30 D): |
$M |
| Avg Inst. Trade (90 D): |
$M |
| Avg Inst. Trade Volume: |
.03M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.41M |
| Avg Closing Trade (30 D): |
$M |
| Avg Closing Trade (90 D): |
$M |
| Avg Closing Volume: |
21.88K |
|
|
| Splits |
|
May 20, 2015:
2:1
|
|
Jan 24, 2014:
2:1
|
|
Oct 05, 2012:
2:1
|
|
|
|
